The impact of ruxolitinib treatment on inflammation‐mediated comorbidities in myelofibrosis and related neoplasms

Publisher： John Wiley & Sons Inc

E-ISSN： 2050-0904|3|6|499-503

ISSN： 2050-0904

Source： Clinical Case Reports, Vol.3, Iss.6, 2015-06, pp. : 499-503

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunologically Mediated Photodermatoses: Diagnosis and Treatment

By Gambichler Thilo  

American Journal of Clinical Dermatology, Vol. 10, Iss. 3, 2009-01 ,pp. : 169-180

Adis International

Access to resources Recommend Favorite

Myeloproliferative neoplasms

By  

Journal of Pain Management, Vol. , Iss. , 2017-01 ,pp. : 34-33

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Recent Advances in the Treatment of AIDS-Related Kaposi's Sarcoma

By Cattelan A.M.  

American Journal of Clinical Dermatology, Vol. 3, Iss. 7, 2002-01 ,pp. : 451-462

Adis International

Access to resources Recommend Favorite

Codelivery of NF-κB Decoy-Related Oligodeoxynucleotide Improves LPD-Mediated Systemic Gene Transfer

By Tan Y.   Zhang J-S.   Huang L.  

Molecular Therapy, Vol. 6, Iss. 6, 2002-12 ,pp. : 804-812

Academic Press

Access to resources Recommend Favorite

The Role of PUVA in the Treatment of Psoriasis: Photobiology Issues Related to Skin Cancer Incidence

By Gasparro F.P.  

American Journal of Clinical Dermatology, Vol. 1, Iss. 6, 2000-11 ,pp. : 337-348

Adis International

Access to resources Recommend Favorite